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The epidemiology of West Nile (WNV) and Usutu virus (USUV) has changed dramatically
over the past two decades. Since 1999, there have been regular reports of WNV
outbreaks and the virus has expanded its area of circulation in many Southern European
countries. After emerging in Italy in 1996, USUV has spread to other countries causing
mortality in several bird species. In 2009, USUV seroconversion in horses was reported
in Italy. Co-circulation of both viruses was detected in humans, horses and birds.
The main vector of WNV and USUV in Europe is Culex pipiens, however, both
viruses were found in native Culex mosquito species (Cx. modestus, Cx. perexiguus).
Experimental competence to transmit the WNV was also proven for native and invasive
mosquitoes of Aedes and Culex genera (Ae. albopictus, Ae. detritus, Cx. torrentium).
Recently, Ae. albopictus and Ae. japonicus naturally-infected with USUV were reported.
While neuroinvasive human WNV infections are well-documented, USUV infections are
sporadically detected. However, there is increasing evidence of a role of USUV in human
disease. Seroepidemiological studies showed that USUV circulation is more common
than WNV in some endemic regions. Recent data showed that WNV strains detected
in humans, horses, birds, and mosquitoes mainly belong to lineage 2. In addition to
European USUV lineages, some reports indicate the presence of African USUV lineages
as well. The trends in WNV/USUV range and vector expansion are likely to continue in
future years. This mini-review provides an update on the epidemiology of WNV and USUV
infections in Southern Europe within a multidisciplinary “One Health” context.
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INTRODUCTION
West Nile virus (WNV) and Usutu virus (USUV) are mosquito-
borne flaviviruses characterized by similar clinical manifestations
and overlapping geographic distribution, host and vector species.
The epidemiology of WNV and USUV has changed dramatically
over the past two decades. Since 1996, an increasing number
of WNV outbreaks in humans and horses were detected, and
the area of its circulation expanded in many Southern European
countries (1). After USUV emergence in Austria in 2001, it
subsequently spread to neighboring countries causing mortality
in several wild bird species, mainly Eurasian blackbirds (2).
However, a retrospective analysis of archived bird tissue samples
from Italy (Tuscany region) in 1996 identified USUV, indicating
a much earlier introduction of this virus into Europe (3).
Since the early 2000s, WNV circulation has been continuously
monitored in some European countries with varying number of
human and horse cases. USUV infections are reported in birds,
while human clinical cases are rarely detected (4–6). However,
there is increasing evidence of a role of USUV in human disease.
Seroepidemiological studies showed that USUV circulation in
humans is more common than WNV in some endemic regions
where both viruses circulate (7).
Until the introduction of WNV lineage 2 in 2004 (8), WNV
lineage 1 was identified as the cause of human outbreaks in
Europe. In the following years, lineage 2 dispersed to the eastern
part of Austria and to Southern European countries (9–11).
Recent data showed that strains detected in humans, horses,
birds, and mosquitoes mainly belong to WNV lineage 2 (6, 12,
13). Although the majority of USUV strains belong to European
USUV lineages, some reports indicate the presence of African
USUV lineages as well (5).
In 2018, WNV infections in Europe increased dramatically
compared to previous transmission seasons. A total of 2,083
human cases and 285 outbreaks among equids were reported
with the largest number detected in Italy, Serbia, and Greece
(14). USUV was detected in asymptomatic blood donors, birds,
and mosquitoes in Italy (15, 16) and in three patients with
neuroinvasive disease in Croatia (6).
The Middle East represents an important transit zone
for bird migration between Africa and Eurasia and provides
valuable information on circulation of WNV/USUV in these
regions (17–19). In Israel, serologic evidence and acute
WNV infections have been reported in humans, horses,
birds, and mosquitoes (20, 21). While strains sequenced
from humans mainly belonged to the WNV lineage 1 (22),
mosquito surveillance revealed a high genetic diversity of
WNV (23). USUV strains detected in mosquitoes belonged
to a putative novel lineage Europe 5 (24). WNV/USUV
infections were also reported in other countries bordering the
Mediterranean Sea (France, Turkey, Cyprus) (5, 25–40). This
mini-review provides an update on the epidemiology/molecular
epidemiology of WNV and USUV infections in Southern Europe
and neighboring countries within a multidisciplinary “One
Health” context.
Data on WNV/USUV infections are presented in Table 1 and
Figure 1.
ALBANIA
Data on WNV infections in Albania are scarce. To date, only
two human cases were reported in 2011 (14). A serological
study conducted among horses from 12 districts in Albania
showed WNV seropositivity of 22.2%, with significant regional
differences (7.7–66.7%). The highest seroprevalence rates were
reported in districts near the Mediterranean Sea, whereas low or
negative seroprevalence was detected in districts located further
inland (41). Data on USUV infection are not available.
BOSNIA AND HERZEGOVINA
There is only one report, in 2013, of two cases of WNV
neuroinvasive disease (WNND) in Bosnia and Herzegovina
(detected in the Tuzla and Kladanj region). Three out of nine
patients screened for WNV met clinical criteria for WNND, of
which two had high serum IgM titres. RT-PCR for WNV RNA
was negative. Since the neutralization test was not performed,
cases were classified according to the European Union case
definition as probable WNV (42). So far, there are no data on
USUV infections in Bosnia and Herzegovina.
BULGARIA
In 2015, the first confirmed human case with fatal outcome
reported in Bulgaria was caused by a Central/Southern-European
lineage 2 WNV (43). Human cases were continuously detected
in the following seasons (12). A nationwide study conducted
among residents of all 28 districts in Bulgaria revealed a 1.5%
WNV seroprevalence with the highest seropositivity (up to 10%)
detected in districts near the Danube River (44). USUV infections
were not documented in Bulgaria.
CROATIA
The first outbreak of human WNND in Croatia was detected
in 2012 in eastern counties, thereafter outbreaks (2013, 2017)
and sporadic cases (2014–2016) were continuously notified in
continental Croatia (4, 45). The largest outbreak was recorded
in 2018 with 54 cases of WNND and 7 cases of WNV fever in
10 of the 21 counties (6). During the 2013 WNV outbreak, the
first three cases of neuroinvasive USUV disease were detected in
Zagreb and surrounding areas (4, 46). Three additional USUV
cases were confirmed in the 2018 outbreak, of which one was fatal
(6). A serological study conducted from 2010 to 2011 showed
WNV antibodies in 3.43% horses and 0.11% cattle with the
highest seropositivity in eastern counties bordering Hungary
and Serbia (47). Seropositivity and acute asymptomatic WNV
infections in horses were detected continuously in subsequent
years. Seroprevalence varied greatly by year and region (0–26%)
with the highest seropositivity in counties with documented
human cases (4, 48). Although passive monitoring of WNV in
birds was established in Croatia in 2012, WNV infections were
not detected until the summer of 2018, when WNV infection
was confirmed serologically in one buzzard presenting with
neurological symptoms, and WNV RNA was detected in two
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TABLE 1 | Summary of West Nile and Usutu virus infections in Southern Europe.
Country First human clinical
cases
Humans Horses Birds Mosquitoes
WNV USUV WNV USUV WNV USUV WNV USUV WNV USUV
Albania 2011
Bosnia and Herzegovina 2013
Bulgaria 2013 Lineage 2
Croatia 2012 2013 Lineage 2 Europe 2 Lineage 2 Europe 2 Europe 2
Cyprus 2016 Lineage 1
France 1962 2016 Africa 2
Africa 3
Greece 2010 Lineage 2 Lineage 2
Israel 1951 Lineage 1 Lineage 1 Europe 5
Lineage 2
Italy 2008 2009 Lineage 1
Lineage 2
Europe 2
Europe 3
Europe 4
Lineage 1
Lineage 2
Lineage 1
Lineage 2
Europe 2 Lineage 1
Lineage 2
Macedonia 2011
Montenegro 2012
Portugal 2004
Serbia 2012 Lineage 2 Lineage 2 Lineage 2 Europe 2
Slovenia 2013
Spain 2004 Lineage 1 Lineage 1 Lineage 2 Africa 2
Turkey 2010 Lineage 1 Lineage 1
Country First human clinical
cases
Humans Horses Birds Mosquitoes
WNV USUV WNV USUV WNV USUV WNV USUV WNV USUV
Albania 2011
Bosnia and Herzegovina 2013
Bulgaria 2013 Lineage 2
Croatia 2012 2013 Lineage 2 Europe 2 Lineage 2 Europe 2 Europe 2
Cyprus 2016 Lineage 1
France 1962 2016 Africa 2
Africa 3
Greece 2010 Lineage 2 Lineage 2
Israel 1951 Lineage 1 Lineage 1 Europe 5
Lineage 2
Italy 2008 2009 Lineage 1
Lineage 2
Europe 2
Europe 3
Europe 4
Lineage 1
Lineage 2
Lineage 1
Lineage 2
Europe 2 Lineage 1
Lineage 2
Macedonia 2011
Montenegro 2012
Portugal 2004
Serbia 2012 Lineage 2 Lineage 2 Lineage 2 Europe 2
Slovenia 2013
Spain 2004 Lineage 1 Lineage 1 Lineage 2 Africa 2
Turkey 2010 Lineage 1 Lineage 1
acute infections (clinical cases/IgM detection/seroconversion/RNA detection) IgG seropositivity.
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FIGURE 1 | Geographic distribution of WNV (a) and USUV (b) infections/seropositivity in southern Europe and neighboring countries. Regional distribution of WNV
(black) and USUV (red) infections (clinical cases/IgM detection/seroconversion/RNA detection) in countries with a high prevalence: Serbia (c), Italy (d), and Greece (e).
dead goshawks fromNorthwest Croatia. Two USUV seropositive
horses were documented in 2011 in Northwest Croatia (49).
In 2018, USUV RNA was detected in one dead blackbird in
Zagreb County (6). To date, none of the mosquito pools tested
were WNV RNA positive. However, USUV-positive mosquito
pools were found in 2016 (Aedes albopictus), 2017 (Culex
pipiens), and 2018 (Cx. pipiens) in Northwestern counties (6, 50).
Sequenced strains from humans, wild birds, and mosquitoes
(2018) confirmed circulation of WNV lineage 2 and USUV
Europe 2 lineage (6).
GREECE
No WNV clinical cases in humans or horses had been reported
in Greece prior to the large WNV outbreak in 2010 when
262 human cases with extremely high fatality rates (17%) were
reported mostly in Central Macedonia (51). The outbreaks
continued in 2011 and 2012 in areas that had not been
affected before (52, 53). Thereafter, outbreaks occurred in
humans every year except 2015 and 2016 (14, 54). The Greek
WNV strains detected during 2010–2018 clustered within the
Central/Southern European subclade of lineage 2 (55). In 2018,
a novel genetic variant was detected that belonged to the
Eastern European subclade of lineage 2 (56). A nationwide
WNV seroprevalence study (2013) showed seropositivity of 1.5%
in the Greek population (57), whilst WNV antibodies were
detected in 4% of horse serum samples (2001–2008) (58). In
2010,WNV infection was reported in 17 horses with neurological
symptoms (59). Furthermore, a highWNV seropositivity (18.6%)
was reported in cattle (60). In Central Macedonia, pigeon
seroprevalence was 54 and 31% at the end of the 2010 and 2011
epidemic seasons, respectively, while one serum was positive for
USUV neutralizing antibodies (61). A small-scale entomological
study performed in Central Macedonia, at the epicenter of the
2010 WNV outbreak found two positive Cx. pipiens pools.
Following this large epidemic, an active mosquito surveillance
system was implemented in Greece for a 3-year period (2011–
2013). Positive Cx. pipiens pools were detected in different areas
of the country and preceded the diagnosed human cases (62).
WNV lineage 2 was detected in Cx. pipiens mosquito pools
during the 2017 outbreak (63).
ITALY
A multi-species national surveillance plan was implemented by
the Italian government in 2002, following the firstWNVoutbreak
(64). In the following years, the program has been adapted
according to the WNV new epidemiological scenarios and a
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National Integrated Plan Monitoring USUV and WNV is in
place since 2016. Human WNV outbreaks were continuously
notified since 2008 (14). WNV lineage 1 was responsible for
reported WNND cases in 2010. In 2011–2012, lineage 1 and 2
co-circulated with a higher proportion of lineage 1 and from
2013 to 2016 lineage 2 was most prevalent (64–66). From 2017,
only lineage 2 has been detected. Since 2008, WNV infections
were continuously detected also in horses and birds (65). WNV
lineage 2 was confirmed in wild birds (2014) (11, 67) and horses
with fatal WNV neuroinvasive infection (68). The presence
of USUV in humans was serologically confirmed for the first
time in four blood donors in 2009 (69). A survey conducted
retrospectively on cerebrospinal fluid (CSF) and serum samples
in Modena (2008–2011) found USUV RNA in 1.1% CSF samples,
while WNV RNA was not detected. USUV antibody levels
were significantly higher (6.57%) compared to that of WNV
(2.96%) indicating that USUV infection is not a sporadic event
in humans in Italy (70). A very high USUV seroprevalence
was found in forestry workers (18.1%) (71). Neuroinvasive
USUV infection was detected for the first time in Italy in two
immunocompromised patients in 2009 (72, 73). During 2017–
2018, USUV Europe 2, 3, and 4 lineages were confirmed in
blood donations in the Lazio region (15). USUV neutralizing
antibodies were detected in horses with a higher seropositivity in
2008 (89.2%) compared to 2009 (7.8%). In the same study, USUV
RNA was found in blackbirds and magpies (Emilia Romagna
and Veneto). Additionally, USUV neutralizing antibodies were
detected in rock pigeon, blackbird and, magpie (74). Culex
pipiens is the mosquito species most involved in the WNV
and USUV circulation in Italy, although other species would
also support the spread of both viruses during winter months
(75). An entomologic investigation conducted in 2013 showed
WNV RNA in 1.9% and USUV in 2.6% mosquito pools. Each
virus was detected mainly in Cx. pipiens pools; however some
pools tested positive for both viruses. The majority of the WNV
strains detected in mosquitoes belonged toWNV lineage 2, while
WNV lineage 1 which predominantly circulated in 2008–2012,
was still detected at low levels until 2016 (64, 76). Sequence
analysis of the first known isolate of USUV to cause human
encephalitis indicated European USUV lineage (77). The whole
genome sequences of USUV strains isolated frommosquitoes and
wild birds in Northern Italy (2010–2014) showed Europe 2 and
Europe 4 lineages, respectively (78).
PORTUGAL
In the summer of 2004, two human cases of WNV infection
were reported in Portugal in tourists (Ria Formosa, Algarve)
(79). Shortly after this report, a WNV monitoring program was
established. The presence of WNV was assessed by serological
surveys in horses (2004–2010), wild birds, and birds from
zoological parks. Detection of WNV antibodies in horses and
birds in all the years covered by the study as well as the
presence of WNV IgM antibodies in horses with neurological
signs supported the evidence of WNV circulation in Portugal
(80). However, no human clinical cases were reported in the
country from 2005 to 2010. In 2010, another WNV human
case was identified (81). Following a 5-year period of apparent
absence, WNV re-emerged in southern Portugal in 2015 when
WNND was diagnosed in a man from the Algarve region (82).
There are no data on USUV infections in Portugal.
SERBIA
The serological surveys (2005–2010) revealed the presence of
WNV IgG antibodies in 3.99% human serum samples in
Vojvodina Province (northern Serbia), with varying yearly rates
(1.97–6.04%) (83). The first outbreak of human WNND was
detected in 2012 (Belgrade and Vojvodina) with 69 reported
and 41 clinically and laboratory confirmed cases (14, 84). Each
year thereafter, seasonal outbreaks were observed. In 2013, 303
cases were reported from 18/25 districts in Serbia; 202 WNND
cases were confirmed with lethality of 11.6%. From 41 to 76
WNND cases were documented annually between 2014 and
2017. The largest epidemic so far was recorded in 2018 with
415 WNND cases detected in 13/25 districts (14). A serological
study conducted in 2009–2010 showed for the first time WNV
neutralizing antibodies in 12% of horses from Vojvodina (85).
Seropositivity and asymptomatic WNV infections in horses
were detected continuously in the subsequent years; 28.6%
seroprevalence from 2010 to 2011 and 49.23% in 2012 in
Vojvodina (86, 87). In 2014, seroconversion was detected in
2.57% horses from the whole country. In addition, in 2015, 2017,
and 2018, acute WNV infections were detected in 0.53, 0.41, and
1.47% of horses tested, respectively (88–90). WNV antibodies
were detected in 7.6% wild birds sampled from 2011 to 2012 in
Vojvodina, of which 133 birds were found dead. Virus presence
was confirmed in 9.87% of tissue samples and in the blood
sample of one bird (91). From 2014 onwards, WNV was detected
in wild birds, with the highest percentage of positive samples
being observed in 2018 when WNV was detected in 11.61%
of tissues and 6.56% of pharyngeal swabs (88–90). All WNV
isolates belonged to WNV lineage 2 (88, 91). Additionally, WNV
antibodies were identified in 15.4% farm pigs, 17.6% wild boars,
and 18.7% roe deer sampled from 2011 to 2012 (Vojvodina)
(92). WNV was detected in mosquitoes for the first time in 2010
in the city of Novi Sad. At that time, 3/841 mosquito pools
were positive by WNV specific RT-PCR. The pools originated
from 66 localities in 29 settlements in Vojvodina (60). More
than 9% of the mosquito pools examined during 2012–2013
were positive for WNV (93). Thereafter, country-wide surveys
detected WNV in 2.31, 2.09, and 2.51% of Cx. pipiens during
2014, 2015, and 2017, respectively, whereas 12.21% of Cx. pipiens
tested positive in 2018. Other naturally-infectedmosquito species
were Ae. vexans and Culiseta annulata (83). All isolates from
mosquitoes (2010–2018) were shown to belong toWNV lineage 2
(83, 88–92, 94–96). USUV neutralizing antibodies were detected
in 1/349 horses (2009-2010), and 4/318 wild boars (2011–2012) in
Vojvodina (85, 92). Additionally, USUV RNA was confirmed in
0.4% of Cx. pipiens pools from Vojvodina in 2014 (74). In 2015,
USUV was detected in 0.93% of Cx. pipiens pools while USUV
antibodies were detected in 5% of human serum samples from
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South Bacˇka District (Vojvodina) (97). Moreover, in 2017, USUV
RNA was detected in 2.75% of Cx. pipiens mosquitoes collected
in Vojvodina. Two isolates were typed as USUV Europe 2 lineage
(98). Thus, far, USUV has not yet been detected in wild birds
in Serbia.
SLOVENIA
Only four human cases of WNV infections were reported in
Slovenia so far. The first case was confirmed in 2013 in a patient
with meningitis. Thereafter, in 2018, three cases of WNND were
confirmed by detection of IgM antibodies in the CSF samples
(99). In 2009, 481/1912 (25.2%) clinically healthy horses were
positive for WNV IgG antibodies (100). From 2003 until 2009,
serum samples from 34 species of songbirds were tested with
WNV seroprevalence of 4.7% (101). Furthermore, from 2010
to 2012, wild bird carcasses were collected through passive
monitoring of wild bird mortality and tested for WNV RNA,
however, there was no evidence of wild bird mortality due to
WNV (102). As well, there was no evidence of USUV circulation
in Slovenia.
SPAIN
The first human clinical case of WNV infection was diagnosed in
2004 in a patient with aseptic meningitis visiting Southwestern
Spain (103). Autochthonous cases were subsequently notified
in 2010, 2016, and 2018 transmission seasons (14, 104). WNV
cases in horses caused by WNV lineage 1 were continuously
reported since 2010 (105). A seroprevalence study conducted
in equine populations of Mallorca Island (2011–2012) showed
seropositivity rates to WNV and USUV of 6.4 and 1.2%,
respectively (106). Another study conducted among horses from
central Spain (2011–2013) found WNV seroprevalence of 1.35%
(107). WNV lineage 1 was isolated from diseased and dead
golden eagles in 2007 (108). In 2011, a survey conducted in
waterfowl used as decoys in Andalusia showed that the frequency
of seropositive decoys ranged 1.5–3.1% for WNV and 4.4–5.9%
for USUV (109). Additionally, WNV and USUV antibodies were
found in 23 and 10% of hunted wild red-legged partridges
and pheasants from Cádiz (2011–2012) (110). In 2012, USUV
was confirmed in two song thrushes (111). WNV and USUV
antibodies were also detected in wild birds (2013) (112) as well
as pigeons and zoo birds from Cordoba (2013–2014) (113).
Moreover, USUV Africa 2 lineage in 2006 (Northeastern Spain)
and 2009 (Southern Spain) as well as WNV lineage 1 in 2008
(Southern Spain) were detected in mosquitoes (114, 115).
CONCLUSIONS AND FUTURE
PERSPECTIVES
An integrated “One Health” surveillance of mosquitoes and
birds in several countries has proven to be useful for early
detection of WNV/USUV circulation and identification of
enzootic areas (48, 61, 116). Virus detection in mosquitoes and
birds preceded human and horse cases (48, 62). In addition, a
high seroprevalence in sentinel animals was detected in areas
with documented human cases (4, 22, 48, 61).
There are still many challenges in the epidemiology of
WNV/USUV. In addition to birds, which are well-known
reservoirs, WNV and USUV antibodies were found in different
animal species. WNV and USUV neutralizing antibodies were
documented in red deer in Spain (117). WNV seropositive
dogs were detected in Italy, Spain, and Corsica Island (118),
while USUV antibodies were found in hunting dogs in Italy
(119). Moreover, WNV and USUV antibodies were found in
gray squirrels in Italy, broadening the host range for these
viruses (120). WNV neutralizing antibodies were also found
in two wild rodents (Apodemus flavicollis) captured in forested
areas of Italy (121). However, the short-term and low-level
viremia makes it unlikely that these animal species play a
role in the WNV transmission cycle. Culex pipiens mosquitoes
appear to be a major vector for WNV and USUV transmission
in Europe, but Cx. modestus and Cx. perexiguus play an
important role in marshlands of some southern countries (115).
However, detection of WNV and USUV in different field-
collected native (Ae. vexans) and invasive (Ae. albopictus, Ae.
japonicus) mosquito species indicates their possible role in
promoting the overwintering of these viruses (75, 83, 122–125).
Additionally, a recently published study identified Cx. torrentium
as a highly competent vector for WNV in Central and Northern
Europe (126).
While several licensed veterinary WNV vaccines are currently
available, there is no WNV or USUV vaccine for humans (127,
128). Since data from Europe indicate that bothWNV andUSUV
appear to be expanding their geographical ranges and the trends
indicate that this spread is likely to continue in future years, the
development of an effective vaccine is urgently needed to protect
at-risk populations from neurological complications.
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